Sign inJoin waitlistJoin the waitlist

Antonio Giordano

Clinical Director Center for Cancer Therapeutic Innovations · Mass General Brigham

Credentials: · · · · · ·

History

Mass General Brigham
Present
Mass General Brigham
Present

Research

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy · 2016 · 4,439 citations
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials
Systematic review or meta-analysis · Journal of Clinical Oncology · 2008 · 314 citations
Detection and characterization of CD133+ cancer stem cells in human solid tumours
PLoS ONE · 2008 · Last of 11 authors · 230 citations

Massimo Cristofanilli
21 papers
Gabriel Hortobagyi
15 papers
Naoto Ueno
13 papers
Sara Tolaney
12 papers
Vicente Valero
12 papers
HG
Hui Gao
11 papers · 7 as a resident
RA
Ricardo Alvarez
10 papers
Wendy Woodward
9 papers
Erica Mayer
6 papers
Nancy Lin
6 papers
GS
Giuseppe Sanguineti
5 papers
PT
Paolo Tarantino
5 papers

Clinical trials

Onvansertib + Paclitaxel In TNBC
Principal investigator · Active not recruiting · Phase 1, Phase 2
Antonio Giordano, MD
2022–2029
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
Principal investigator · Completed
Medical University of South Carolina
2017–2020
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2033
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2025–2028